WhichRecall
Class I — UrgentReported 2024-12-11

PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com

Recalled by Boulla LLC

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Advertisement
Recall Number
D-0084-2025
Classification
Class I
Status
Ongoing
Category
drug
Initiated
2024-11-04
Reported
2024-12-11
Distribution
Nationwide within the United States
Code Info
Lot #: 230811, Exp: 08/11/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement